Cellectis (CLLS) Other Working Capital Changes (2015 - 2023)
Cellectis (CLLS) posted Other Working Capital Changes of -$98000.0 for Q2 2023, down 135.25% on a QoQ basis from $278000.0 in Q1 2023, and up 19.67% year-over-year from -$81890.4 in Q2 2022.
Cellectis (CLLS) has 9 years of Other Working Capital Changes data on file, last reported at -$98000.0 in Q2 2023.
- In Q2 2023, Other Working Capital Changes rose 19.67% year-over-year to -$98000.0; the TTM figure through Jun 2023 stood at -$153000.0 (down 134.54% YoY), while the FY2015 annual figure was $1.2 million, up 114.48% from the prior year.
- Other Working Capital Changes eased to -$98000.0 in Q2 2023, from $278000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $324000.0 in Q1 2022 and bottomed at -$19.1 million in Q1 2020.
- A 5-year average of -$1.4 million and a median of -$73500.0 in 2019 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2020 — Other Working Capital Changes tumbled 20234.04% — and 2021, when it soared 401.89%.
- Year by year, Other Working Capital Changes stood at $75000.0 in 2019, then slumped by 700.0% to -$450000.0 in 2020, then jumped by 118.0% to $81000.0 in 2021, then slumped by 360.49% to -$211000.0 in 2022, then jumped by 53.55% to -$98000.0 in 2023.
- The last three Other Working Capital Changes figures came in at -$98000.0 (Q2 2023), $278000.0 (Q1 2023), and -$211000.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -98,000.00 |
| Jun 30, 2023 | -98,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Sep 30, 2022 | -211,000.00 |
| Sep 30, 2022 | -211,000.00 |
| Jun 30, 2022 | -122,000.00 |
| Jun 30, 2022 | -122,000.00 |
| Mar 31, 2022 | 324,000.00 |
| Mar 31, 2022 | 324,000.00 |
| Sep 30, 2021 | 81,000.00 |
| Sep 30, 2021 | 81,000.00 |
| Jun 30, 2021 | 160,000.00 |
| Jun 30, 2021 | 160,000.00 |
| Mar 31, 2021 | -179,000.00 |
| Mar 31, 2021 | -179,000.00 |
| Sep 30, 2020 | -450,000.00 |
| Sep 30, 2020 | -450,000.00 |
| Jun 30, 2020 | -53,000.00 |
| Jun 30, 2020 | -53,000.00 |
| Mar 31, 2020 | -19.11 Mn |
| Mar 31, 2020 | -19.11 Mn |
| Sep 30, 2019 | 75,000.00 |
| Sep 30, 2019 | 75,000.00 |
| Jun 30, 2019 | 148,000.00 |
| Jun 30, 2019 | 148,000.00 |
| Mar 31, 2019 | -94,000.00 |
| Mar 31, 2019 | -94,000.00 |
| Sep 30, 2018 | 88,000.00 |
| Sep 30, 2018 | 88,000.00 |
| Jun 30, 2018 | -3.45 Mn |
| Jun 30, 2018 | -3.45 Mn |
| Mar 31, 2018 | -3.62 Mn |
| Mar 31, 2018 | -3.62 Mn |
| Sep 30, 2017 | -4.01 Mn |
| Sep 30, 2017 | -4.01 Mn |
| Jun 30, 2017 | -4.91 Mn |
| Jun 30, 2017 | -4.91 Mn |
| Mar 31, 2017 | -4.06 Mn |
| Mar 31, 2017 | -4.06 Mn |
| Sep 30, 2016 | -3.04 Mn |
| Sep 30, 2016 | -3.04 Mn |
| Jun 30, 2016 | -6.29 Mn |
| Jun 30, 2016 | -6.29 Mn |
| Mar 31, 2016 | -5.02 Mn |
| Mar 31, 2016 | -5.02 Mn |
| Dec 31, 2015 | 18.50 Mn |
| Dec 31, 2015 | 18.50 Mn |
| Sep 30, 2015 | -6.28 Mn |
| Sep 30, 2015 | -6.28 Mn |
| Jun 30, 2015 | -5.53 Mn |
| Jun 30, 2015 | -5.53 Mn |
| Mar 31, 2015 | -5.78 Mn |
| Mar 31, 2015 | -5.78 Mn |